UNSPSC 51383317: Felbinac ethyl ester

This classification denotes a nonsteroidal antiinflammatory drug C16H16O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 978ZPS989U, chemically known as (1,1'-biphenyl)-4-acetic acid, ethyl ester, but more generally known as felbinac ethyl ester, which bears US NIH Compound Identifier 26436. Most nations, for tariff and trade purposes, schedule felbinac ethyl ester under HS 29163900 and SITC 51379. As of Q4 2014, FELBINAC ETHYL ESTER remains US FDA's Preferred Term for this commodity. SMILES: CCOC(=O)CC1CCC(CC1)C2CCCCC2.

UNSPSC 51383317 Felbinac ethyl ester (Commodity) shows minimal direct relevance to recent state and local procurement activity. The code nominally identifies a topical anti-inflammatory pharmaceutical ingredient, but the three most recent opportunities tagged under this code involve naloxone procurement, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products — none of which align with felbinac ethyl ester specifically. The mismatch suggests either a coding error in how opportunities were tagged or a lack of recent state and local solicitations for felbinac ethyl ester itself. State and local health and human services agencies, including county public health departments and state pharmacy benefit programs, are the primary issuing bodies appearing in recent activity, but their actual procurement focus does not track to this commodity code's scope.

Geographic representation in the tagged opportunities spans Florida (Seminole County), Texas (Texas Health and Human Services Commission), and Minnesota (Minnesota Multistate Cooperative Purchasing Alliance), though none of these jurisdictions appear to be actively seeking felbinac ethyl ester. The Seminole County IFB 60459723LAS, posted June 30, 2026, sought naloxone and drug deactivation systems with a response deadline of July 26, 2023 (a date inconsistency in the source), while the Texas HHS Commission's RFI HHS0017013 (April 3, 2026) and the Minnesota MMCAP RFP S1070000015802 (due March 26, 2026) targeted broader pharmaceutical supply and generic product categories. No recent opportunities explicitly soliciting felbinac ethyl ester appear in the source material. Unless this code is regularly used in state and local procurement for this specific ingredient and opportunities simply do not appear in the recent block, the code warrants flagging as low-activity or potentially miscategorized in current state and local contracting.